Peter Salzmann, Chief Executive Officer at Immunovant, Inc. (IMVT), sold 30,878 shares at $20.86 ($644K) on 2025-02-19, disclosed to the SEC on 2025-02-21.
Open-market sale of $644k IMVT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.86 | 15,439 | $322K | 50.0% |
| 2 | $20.86 | 15,439 | $322K | 50.0% |
| Total | $20.86 avg | 30,878 | $644K | 100% |
| Filing → |
| IMVT | SELL | 2025-01-17 | $408K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $246K | — | Filing → |
| IMVT | SELL | 2024-11-22 | $850K | — | Filing → |